Answer
Nov 07, 2024 - 01:52 PM
Xeljanz (tofacitinib) should not be taken by individuals with a known hypersensitivity to tofacitinib or any of its ingredients. It is also not recommended for people with active infections, such as tuberculosis or other serious infections, as it can suppress the immune system. Additionally, patients with a history of blood clots or certain liver problems should consult their healthcare provider before using Xeljanz.
